UpFront

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

INDUSTRY at Large

Milestones… Spectrum Celebrates 15 Years Spectrum, a health and science communications agency, is ­celebrating its 15th ­anniversary. The independent agency, which was founded by John Seng in 1996, is ­committed to achieving the goals of clients who are involved with issues, products, provider services or research in life and human health sciences. Roska Celebrates 30 Year Anniversay Roska Healthcare Advertising closed out 2011 celebrating 30 years of ­business, marked by continuing innovation in pharmaceutical marketing communications. Roska Healthcare is redefining ­relationships and multichannel ­marketing campaigns for healthcare brands by creating deeper relationships between HCPs and patients, sales reps and HCPs, as well as agencies and clients. Market Turmoil Overshadows Biotech Successes Life-sciences companies across the globe during 2011 raised $82.4 billion in public ­financings, up from $65 billion in 2010, according to Burrill & Company. And while the biotech ­industry in 2011 scored notable victories with major drug approvals, deals, and advancements, global economic worries and political fights over debt in Europe and the U.S. weighed heavily on the industry. Amgen Names New CEO Robert Bradway, ­currently president and chief operating officer of Amgen, will become CEO of the company in May. He replaces Kevin W. Sharer, who has been chairman and CEO since 2000. Mr. ­Bradway, 48, joined Amgen in 2006 as a VP in operations. He was appointed CFO in 2007 and was named president and chief operating officer in 2010. Novo Nordisk and Chip Ganassi Racing renew Partnership Novo Nordisk and Chip Ganassi Racing Teams Inc. have announced the multi-year extension of their partnership. Novo Nordisk will remain the primary sponsor of the No. 83 Novo Nordisk Chip Ganassi ­Racing entry, driven by Charlie Kimball — the first ­licensed driver with type 1 diabetes in INDYCAR. ­Mr. Kimball uses Novo Nordisk’s Levemir and NovoLog with FlexPen to help manage his diabetes. Racing fans can get live updates from Charlie Kimball on ­Twitter @racewithinsulin ­(http://mobile.twitter.com/racewithinsulin). “ Our aspiration at ­Millennium is to cure ­cancer and it’s a bold goal and one we don’t ­necessarily think has been achieved yet…” Dr. Deborah Dunsire President and CEO, Millennium Quote of the Month… Podcasts How the New Role of the CRO Affects Patient Enrollment Thought Leader: Dr. Richard Malcolm, Acurian The Evolving Social Media Lifecycle in Pharma Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, Alexander Gochtovtt, Cognizant Transformative Leadership Thought Leader: Dr. Deborah Dunsire, ­Millennium: The Takeda Oncology Company Understanding the Impact of Drug Induced Liver Injury on Drug Development Thought Leader: Dr. Steve Lobel, PPD White papers Transforming R&D Productivity by Redefining Success in Clinical Trial Enrollment Sponsored by: Acurian Adaptive Social Media in Life Sciences Sponsored by: Cognizant Understanding Drug-Induced Liver Injury in the Context of Pharmaceutical Development Sponsored by: PPD According to Manhattan Research’s ePharma Consumer study, 42% of online adults agree that pharmaceutical ­companies should be involved in online health communities for consumers; 19% disagree that pharma should participate in this type of forum.

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK